https://www.selleckchem.com/pr....oducts/mg-101-alln.h
Current treatment options for patients with stage 5 chronic kidney disease before dialysis (predialysis CKD-5) are determined by individual circumstances, economic factors, and the doctor's advice. This study aimed to explore the plasma metabolic traits of patients with predialysis CKD-5 compared with maintenance hemodialysis (HD) and peritoneal dialysis (PD) patients, to learn more about the impact of the dialysis process on the blood environment. Our study enrolled 31 predialysis CKD-5 patients, 31 HD patients, and 30 PD patients.
Tycka om
Kommentar
Dela med sig
